ArticleThe Journal of infectious diseases2020

Leveraging a Landmark Trial of Primary Cardiovascular Disease Prevention in Human Immunodeficiency Virus: Introduction From the REPRIEVE Coprincipal Investigators.

Steven K Grinspoon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.